BIO-PATH HOLDINGS, INC. (BPTH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 15K 30K 45K Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q2 '14: 0 Q3 '14: 0 Q4 '14: 0 Q1 '15: 0 Q2 '15: 0 Q3 '15: 0 Q4 '15: 0 Q1 '16: 0 Q2 '16: 0 Q3 '16: 0 Q4 '16: 13K Q1 '17: 13K Q2 '17: 13K Q3 '17: 13K Q4 '17: 37K Q2 '13 Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q4 '17

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-18M -12M -6M 0 6M 12M 18M Q4 '20: -10.9M Q1 '21: -10M Q2 '21: -9.8M Q3 '21: -8.9M Q4 '21: -10.4M Q1 '22: -11.4M Q2 '22: -12.6M Q3 '22: -14M Q4 '22: -13.9M Q1 '23: -15.8M Q2 '23: -17.1M Q3 '23: -16.8M Q4 '23: -15.8M Q1 '24: -14.2M Q2 '24: -13M Q3 '24: -12.4M Q4 '24: -12M Q1 '25: -11.5M Q2 '25: -13.1M Q3 '25: -10.9M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Net Income TTM

-18M -12M -6M 0 6M 12M 18M Q4 '20: -10.9M Q1 '21: -10M Q2 '21: -9.8M Q3 '21: -8.9M Q4 '21: -10.4M Q1 '22: -11.4M Q2 '22: -12.6M Q3 '22: -14M Q4 '22: -13.9M Q1 '23: -15.8M Q2 '23: -17M Q3 '23: -16.7M Q4 '23: -16.1M Q1 '24: -14M Q2 '24: -11.6M Q3 '24: -10.5M Q4 '24: -9.9M Q1 '25: -9.6M Q2 '25: -12.3M Q3 '25: -11.2M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-18M -12M -6M 0 6M 12M 18M Q4 '20: -11M Q1 '21: -10M Q2 '21: -9.2M Q3 '21: -9.7M Q4 '21: -9.9M Q1 '22: -10.9M Q2 '22: -12.4M Q3 '22: -12.9M Q4 '22: -15.1M Q1 '23: -16.2M Q2 '23: -15.3M Q3 '23: -14.7M Q4 '23: -11.5M Q1 '24: -8.9M Q2 '24: -9.9M Q3 '24: -10.5M Q4 '24: -11.6M Q1 '25: -11.9M Q2 '25: -7.9M Q3 '25: -4.5M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Free Cash Flow TTM

-9M -6M -3M 0 3M 6M 9M Q3 '16: -7.6M Q4 '16: -8.5M Q1 '17: -8.4M Q2 '17: -8.6M Q3 '17: -8.2M Q4 '17: -8.5M Q1 '18: -7.9M Q2 '18: -7.1M Q3 '18: -7.1M Q4 '18: -6.1M Q1 '19: -6.5M Q2 '19: -7M Q3 '19: -7.4M Q4 '19: -8.4M Q4 '16 Q2 '17 Q4 '17 Q2 '18 Q4 '18 Q2 '19 Q4 '19

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 3.5M 7M 10.5M Q1 '21: 5.7M Q2 '21: 7M Q3 '21: 7M Q1 '22: 7.2M Q2 '22: 7.2M Q3 '22: 7.2M Q1 '23: 398K Q2 '23: 398K Q3 '23: 503K Q1 '24: 647K Q2 '24: 1.6M Q3 '24: 3M Q1 '25: 7.1M Q2 '25: 8.3M Q3 '25: 8.5M Q1 '26: 9.3M Q2 '21 Q1 '22 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-75.00 -50.00 -25.00 0.00 25.00 50.00 75.00 Q4 '20: -2.82 Q1 '21: -2.35 Q2 '21: -2.06 Q3 '21: -1.55 Q4 '21: -1.57 Q1 '22: -1.61 Q2 '22: -1.77 Q3 '22: -1.97 Q4 '22: -38.12 Q1 '23: -50.90 Q2 '23: -61.12 Q3 '23: -66.99 Q4 '23: -34.54 Q1 '24: -26.17 Q2 '24: -16.69 Q3 '24: -11.03 Q4 '24: -4.12 Q1 '25: 0.36 Q2 '25: 0.97 Q3 '25: 1.56 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.